| Literature DB >> 26146833 |
Paula Costa Santos1, Lis Maurente Lehmann1, Carolina Lorenzi1, Carolina Hirsch1, Paula Lima Telmo1, Gabriela Torres Mattos1, Priscila Silva Cadore1, Gabriel Baracy Klafke1, Maria Elisabeth Aires Berne2, Carla Vitola Gonçalves3, Carlos James Scaini1.
Abstract
BACKGROUND: Human toxocariasis is a parasitic zoonosis with a worldwide distribution but is underdiagnosed with an underestimated impact on human health. The ingestion of embryonated eggs of Toxocara spp. present on the hands or in contaminated food or water is the main mode of infection. The only record of Toxocara congenital infection in humans occurred in a premature infant. Helminth infections during pregnancy may be associated with reproductive disorders. Studies investigating the occurrence of toxocariasis in pregnancy are scarce, as is research on the possible implications of these parasites in reproductive health. The aim of this study was to determine the seroprevalence of antibodies to Toxocara spp. in pregnant women and to identify risk factors associated with its infection. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2015 PMID: 26146833 PMCID: PMC4492739 DOI: 10.1371/journal.pone.0131058
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The seropositivity (IgG) for Toxocara spp. according to sociodemographic data of the pregnant women attended at the University Hospital in Rio Grande-RS, Brazil from May 2011 to April 2012 (n = 280).
| Variable | Samples | Positivity | Prevalence Ratio | Confidence interval CT 95% |
| ||
|---|---|---|---|---|---|---|---|
| N | (%) | N | (%) | ||||
|
| 0.431 | ||||||
| 13–19 | 58 | (20.7) | 05 | (8.6) | 1 | ||
| 20–24 | 82 | (29.3) | 06 | (7.3) | 1.21 | 0.46–3.10 | |
| 25–29 | 73 | (26) | 04 | (5.5) | 0.81 | 0.27–2.38 | |
| 30–34 | 41 | (14.6) | 02 | (4.9) | 0.73 | 0.17–3.05 | |
| 35 or more | 26 | (9.4) | 01 | (3.8) | 0.57 | 0.08–4.14 | |
|
|
| ||||||
| 3 or more | 78 | (27.8) | 01 | (1.3) | 1 | ||
| Up to 2 | 146 | (52.1) | 02 | (1.4) | 0.11 | 0.02–0.48 | |
| ≤ 1 | 56 | (20.0) | 15 | (26.8) | 20.0 | 5.9–66.70 | |
|
|
| ||||||
| Periphery | 180 | (64.3) | 08 | (4.4) | 1 | ||
| Downtown | 36 | (12.8) | 03 | (8.3) | 1.35 | 0.41–4.45 | |
| BalnearyCassino | 18 | (6.4) | 04 | (22.2) | 4.15 | 1.52–11.3 | |
| Rural | 29 | (10.4) | 02 | (6.9) | 1.12 | 0.27–4.64 | |
| Another municipality | 17 | (6.1) | 01 | (5.9) | 0.97 | 0.12–7.77 | |
(Chi-square, p ≤0,05)
The seropositivity (IgG) for Toxocara spp. according to the epidemiological factors in the pregnant women attended at the University Hospital of Rio Grande—RS, from May 2011 to April 2012(n = 280).
| Variable | Sample | Positivity | Prevalence Ratio | Confidence interval CI 95% |
| ||
|---|---|---|---|---|---|---|---|
| N | (%) | N | (%) | ||||
|
|
| ||||||
| No | 134 | (47.9) | 02 | (1.5) | 1 | ||
| Yes | 146 | (52.1) | 16 | (11) | 7.45 | 1.75–31.81 | |
|
| 0.822 | ||||||
| No | 231 | (82.5) | 15 | (6.5) | 1 | ||
| Yes | 49 | (17.5) | 3 | (6.1) | 0.94 | 0.28–3.13 | |
|
| 0.092 | ||||||
| No | 224 | (80) | 17 | (7.6) | 1 | ||
| Yes | 56 | (20) | 1 | (1.8) | 0.24 | 0.03–1.73 | |
|
| 0.395 | ||||||
| No | 196 | (70) | 11 | (5.6) | 1 | ||
| Yes | 84 | (30) | 7 | (8.3) | 1.48 | 0.59–3.69 | |
|
| 0.615 | ||||||
| No | 182 | (65) | 13 | (7.1) | 1 | ||
| Yes | 98 | (35) | 5 | (5.1) | 0.71 | 0.26–1.94 | |
|
| 0.422 | ||||||
| No | 30 | (10.7) | 3 | (10) | 1 | ||
| Yes | 250 | (89.3) | 15 | (6) | 0.60 | 0.18–1.95 | |
|
|
| ||||||
| No | 75 | (26.8) | 1 | (1.3) | 1 | ||
| Yes | 205 | (73.2) | 17 | (8.1) | 6.38 | 0.86–47.16 | |
|
| 0.755 | ||||||
| No | 193 | (68.9) | 13 | (6.7) | 1 | ||
| Yes | 87 | (31.1) | 5 | (5.7) | 0.85 | 0.31–3.31 | |
|
| 0.366 | ||||||
| No | 97 | (34.6) | 8 | (8.2) | 1 | ||
| Yes | 183 | (65.4) | 10 | (5.5) | 0.66 | 0.27–1.62 | |
(Chi-square, p ≤0,05)
The seropositivity (IgG) for Toxocara spp. according to the obstetric history and the blood eosinophilia status in the pregnant women attended at the University Hospital of Rio Grande—RS, from May 2011 to April 2012 (n = 280).
| Variable | Sample | Positivity | Prevalence Ratio | Confidence interval CI 95% |
| |||
|---|---|---|---|---|---|---|---|---|
| N | (%) | N | (%) | |||||
|
| 0.771 | |||||||
| No | 220 | (78.6) | 15 | (6.8) | 1 | |||
| Yes | 60 | (21.4) | 3 | (5.0) | 0.73 | 0.21–2.45 | ||
|
| 0.443 | |||||||
| No | 248 | (88.6) | 15 | (6.8) | 1 | |||
| Yes | 32 | (11.4) | 3 | (9.4) | 1.55 | 0.47–5.06 | ||
|
| 0.302 | |||||||
| No | 240 | (85.7) | 14 | (5.8) | 1 | |||
| Yes | 40 | (14.3) | 4 | (10) | 1.71 | 0.59–4.94 | ||
|
| 0.302 | |||||||
| No | 240 | (85.7) | 14 | (5.8) | 1 | |||
| Yes | 40 | (14.3) | 4 | (10) | 1.71 | 0.59–4.94 | ||
|
| 0.675 | |||||||
| No | 262 | (93.6) | 17 | (6.5) | 1 | |||
| Yes | 18 | (6.4) | 1 | (5.6) | 0.91 | 0.12–6.47 | ||
(Chi-square, p ≤0,05)